1. gerhart1
2. learningtolearn2
3. larryendo
1.learningtolearn2 03/22/2018
Trillium Therapeutics' TTI-621 Receives Orphan Drug Designation for the Treatment of Cutaneous T-Cell Lymphoma
2.larryendo 03/20/2018
Has been granted an Orphan Drug Designation to TTI-621 for the treatment of cutaneous T-cell lymphoma
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW